BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6176791)

  • 21. Response to total sleep deprivation before and during treatment with fluvoxamine or maprotiline in patients with major depression--results of a double-blind study.
    Kasper S; Voll G; Vieira A; Kick H
    Pharmacopsychiatry; 1990 May; 23(3):135-42. PubMed ID: 2115680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
    Ahles S; Gwirtsman H; Halaris A; Shah P; Schwarcz G; Hill MA
    J Clin Psychiatry; 1984 Nov; 45(11):460-5. PubMed ID: 6208185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maprotiline treatment in depression. A perspective on seizures.
    Dessain EC; Schatzberg AF; Woods BT; Cole JO
    Arch Gen Psychiatry; 1986 Jan; 43(1):86-90. PubMed ID: 3942475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake.
    Harper B; Hughes IE
    Br J Pharmacol; 1977 Apr; 59(4):651-60. PubMed ID: 870126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A profile of the clinical effectiveness of second generation antidepressive agents].
    Kabes J; Dostal T; Balon R; Papezová H
    Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
    [No Abstract]   [Full Text] [Related]  

  • 26. Case report of hepatotoxicity associated with maprotiline.
    Weinstein RP; Gosselin JY
    Can J Psychiatry; 1988 Apr; 33(3):233-4. PubMed ID: 3383098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug fever due to nomifensine treatment in patients with endogenous depression.
    Nielsen JL; Lund NO
    Int Pharmacopsychiatry; 1981; 16(1):66-8. PubMed ID: 7298271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind trial of mianserin and nomifensine in depressed outpatients.
    Hamouz W; Van Dorth R; Pinder RM; Stulemeijer SM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):219S-225S. PubMed ID: 6337609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seizures associated with maprotiline.
    Kim WY
    Am J Psychiatry; 1982 Jun; 139(6):845-6. PubMed ID: 6805342
    [No Abstract]   [Full Text] [Related]  

  • 30. Maprotiline-induced myoclonus.
    Kettl P; DePaulo JR
    J Clin Psychopharmacol; 1983 Aug; 3(4):264-5. PubMed ID: 6886043
    [No Abstract]   [Full Text] [Related]  

  • 31. Maprotiline-induced ataxia.
    Buckler RA; Friedman JH
    J Clin Psychopharmacol; 1986 Dec; 6(6):382-3. PubMed ID: 3805338
    [No Abstract]   [Full Text] [Related]  

  • 32. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Maprotiline and its undesired effects].
    Tesarová O
    Act Nerv Super (Praha); 1982 May; 24(2):90-2. PubMed ID: 7048836
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutaneous vasculitis from maprotiline.
    Oakley AM; Hodge L
    Aust N Z J Med; 1985 Apr; 15(2):256-7. PubMed ID: 3161496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

  • 36. Maprotiline hydrochloride and convulsions: a case report.
    Schwartz L; Swaminathan S
    Am J Psychiatry; 1982 Feb; 139(2):244-5. PubMed ID: 6798885
    [No Abstract]   [Full Text] [Related]  

  • 37. [Heart conduction disorders in acute maprotiline poisoning].
    Colpart E; Manoury B; Daumal M; Boutillier C
    Ann Fr Anesth Reanim; 1986; 5(6):623-4. PubMed ID: 3826798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seizures and maprotiline.
    Bick P
    J Clin Psychiatry; 1982 Oct; 43(10):434. PubMed ID: 7118841
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatotoxicity associated with maprotiline therapy: case report.
    Moldawsky RJ
    J Clin Psychiatry; 1984 Apr; 45(4):178-9. PubMed ID: 6715293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Speech blockage induced by maprotiline.
    Sandyk R
    Am J Psychiatry; 1986 Mar; 143(3):391-2. PubMed ID: 3953878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.